quarterly, page-16

easy9

ALT definitely not a 1 trick pony. They have several products, each with huge potential markets but each a different strategy required for distribution, commercialisation and sales.

From what I hear, the pelvic floor has a huge target market and market penetration is expected to be a great deal easier than the burette as it is not dominated by a few majors and retail consumers can purchase it directly, unlike the burette which requires direct supply to hospitals - meaning they can sell direct to the public or through clinics / doctors. It is all a marketing play.

I imagine they are keeping the pelvic floor quiet while the lead up to sales as to not confuse the market, as the burette is the forefront product.

Don't forget, the also have the autoflush that can be produced for a few cents, saves $2.50 per flushing event required with normal burettes and can be used on most burettes now. Another product that pays for itself.

From the research I've done, their burette coupled with the autoflush device, nothing on market comes close to it in terms of functionality, safety and cost savings. They just have to penetrate the major distributors which is well worth the wait when it happens.